Skip to main content

Robert G. Kidwell

Member

[email protected]

+1.202.661.8752

Share:

Rob’s Washington, DC-based competition and trade regulation practice involves counseling on the competitive implications of business strategies, regulatory matters, and litigation. He defends clients in complex litigation and in merger and regulatory reviews by agencies such as the US Department of Justice, the Federal Trade Commission, the Federal Communications Commission, and the Committee on Foreign Investment in the US. Rob’s clients include media and telecommunications companies, health systems and providers, national retailers, trade associations, life sciences companies, and technology companies.

Rob specializes in clearly explaining strategic risks and their relative values in order to help senior executives make informed decisions. He provides advice to clients from across the country and around the world in high-profile matters including:

  • Complex litigation (class action and otherwise)
  • Antitrust issues in mergers and acquisitions / second requests
  • Strategic business planning and risk management 
  • Regulatory issues arising from foreign investments in U.S. businesses (particularly Chinese investment)
  • Federal and state regulatory investigations
  • Policy advocacy and notice-and-comment rulemaking 
  • Appellate review of agency action
  • Trade association counseling
  • Privacy and data security
  • Consumer protection and unfair/deceptive trade practices

Rob represents clients in numerous markets, including:

  • Media content and distribution
  • Wireless communications
  • Health care providers and services
  • Life sciences
  • Technology
  • Retail & Consumer Products
  • Trade associations and non-profits

He has written and spoken widely on litigation risk management and cost containment and on issues faced by businesses when they interact with federal and state enforcers and administrative agencies.

Rob is an active supporter of the firm’s pro bono program, providing representation to numerous indigent clients before the Social Security Administration and in local family and domestic relations courts. He has provided corporate and business planning advice to the National Network to End Domestic Violence and other non-profit clients. He is also an active supporter of the firm’s mentoring and sponsorship program.

Prior to his career in the law, Rob was an on-air radio personality and station production director in Lexington, KY.

Education

  • Georgetown University (JD)
  • University of Kentucky (BA)

Experience

  • Co-lead trial counsel in the 2020 jury trial of a nationwide class action alleging global price fixing in sales of capacitors.
  • Lead U.S. antitrust counsel for Qiagen N.V. in its $11 billion sale to Thermo Fisher Scientific, announced in March 2020.
  • Successfully represented a global contract manufacturer before the Committee on Foreign Investment in the United States (CFIUS) in its 2020 acquisition by a Chinese investor.
  • Serves as ongoing antitrust counsel to one of the nation’s largest and most respected integrated physician/hospital provider network on matters including mergers, affiliations, investigations, and litigation.
  • Represented the nation’s premier retail pharmacy chain in its $27 billion industry-transforming acquisition of a “big three” pharmacy benefits manager.
  • Serves as ongoing antitrust counsel to several of the world’s leading genetic and molecular diagnostic test developers and providers.
  • Lead counsel for three separate cable operators in sprawling multidistrict litigation involving more than 30 separate suits filed around the country relating to the alleged tying of cable set-top boxes to certain cable services.
  • Serves as ongoing antitrust counsel to one of the world’s largest and most recognizable brands in healthcare equipment and technology.
  • Serves as ongoing antitrust, regulatory, and litigation counsel to several of the nation’s leading cable, media, and wireless telecommunications companies and trade associations.
  • Provides ongoing antitrust and foreign investment counsel to dozens of early-stage companies in biotech, healthcare, green energy, and high-tech manufacturing.

Recognition & Awards

  • Washington DC Super Lawyers: Rising Star – Antitrust Litigation (2013 – 2014)
  • Washington DC Super Lawyers: Antitrust Litigation (2017 - 2019)

Viewpoints

Antitrust Viewpoint Thumbnail

Treasury Issues Final Rule Amending CFIUS Mandatory Filing Requirements

September 17, 2020 | Blog | By Robert Kidwell, Tinny Song

Read more
Antitrust Viewpoint Thumbnail

DOJ and the FTC Publish Vertical Merger Guidelines

July 13, 2020 | Blog | By Joseph Miller, Bruce Sokler, Robert Kidwell, Evan Moore

Read more
Antitrust Viewpoint Thumbnail
On Wednesday, an FTC Commissioner used the occasion of a routine report to Congress to send a warning shot to private equity firms, especially those rolling up health care providers. Commissioner Rohit Chopra, an advisor to Senator Elizabeth Warren before he joined the Commission in May 2018, released this statement focusing particular scrutiny on private equity (PE) firms and the practice of acquiring physician groups, especially emergency medicine, anesthesiology, and other services that generate “surprise” out of network charges for otherwise insured patients.
Read more
Real Estate, Construction & Infrastructure Viewpoints Thumbnail

Newly Expanded CFIUS Jurisdiction

February 12, 2020 | Alert | By Cory S. Flashner, Steve Ganis, Robert Kidwell, Alyssa C. Scruggs

This alert covers new regulations taking effect on February 13, 2020 that significantly broaden CFIUS’s jurisdiction by granting it significant new review power over foreign investments in US businesses and real estate.
Read more
Viewpoint Thumbnail

2020 HSR Notification Thresholds Announced

January 28, 2020 | Alert | By Bruce Sokler, Robert Kidwell, Farrah Short

Read about the FTC’s 2020 “size of transaction” and “size of person” thresholds for premerger reporting under the Hart-Scott-Rodino Antitrust Improvements Act of 1976.
Read more
Viewpoint Thumbnail
Read about the Sixth Circuit's rejection of a hospital plaintiff’s per se antitrust claim against a dominant competitor in The Medical Center at Elizabeth Place, LLC v. Atrium Health System.
Read more
Viewpoint Thumbnail

CFIUS Review and International Business Transactions

April 12, 2019 | Video | By Robert Kidwell

Rob Kidwell provides an overview of the Committee on Foreign Investment in the United States (CFIUS) and the recent amendments to the statute governing the committee as well as how these changes impact business transactions.
Read more
Viewpoint Thumbnail

2019 HSR Notification Thresholds Announced

February 19, 2019 | Alert | By Bruce Sokler, Robert Kidwell, Farrah Short

Read about the FTC’s new “size of transaction” and “size of person” thresholds requiring reporting under the Hart-Scott-Rodino Antitrust Improvements Act of 1976.
Read more
Viewpoint Thumbnail

Divergent Views on Vertical Mergers Apparent in FTC’s Staples Merger Consent

February 4, 2019 | Advisory | By Bruce Sokler, Robert Kidwell, Farrah Short

Read about FTC commissioners’ divergent views on vertical mergers detailed in statements filed with a proposed consent order regarding Staples’ acquisition of Essendant.
Read more

Not Just Mergers – FTC Highlights Commonly Missed HSR Reportable Transactions

May 16, 2018 | Alert | By Bruce Sokler, Robert Kidwell, Farrah Short

The Premerger Notification Office (the “PNO”) of the Federal Trade Commission (the “FTC”) recently issued a reminder about often overlooked “transactions” that may require notification under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (the “HSR Act”).
Read more

News & Press

Press Release Thumbnail
Firm plays a key role in the largest health care acquisition to date in 2020.
Though merger reviewers at the Department of Justice and the Federal Trade Commission (FTC) are back at work after the 30+ day government shutdown, antitrust experts note that backlog and the possibility of another shutdown are significantly impacting the certainty merging parties rely on. Mintz Member Rob Kidwell is among the industry sources quoted.

This article in The Boston Globe looks at how a law – signed in August and which took effect in November – is impacting Boston’s start-up community. The specific law is the Committee on Foreign Investment in the United States (CFIUS) and it requires foreign entities investing in U.S. companies in 27 “critical” industries to be properly documented with CFIUS at the risk of penalties.
This feature article looks at the potential increased scrutiny hospitals may face from the Federal Trade Commission (FTC) in terms of anticompetitive behavior. Rob Kidwell, an antitrust Member with Mintz, is among the industry sources providing commentary.
A team of Mintz attorneys - Mike Renaud, Rob Kidwell and Rob Moore - authored this issues response op-ed discussing the Department of Justice's (DOJ) statements on intellectual property rights, "the New Madison Approach." This approach marks a return to the core principles on which the patent laws are predicated.
Mintz is pleased to announce that eight attorneys have been named Washington, D.C. Super Lawyers for 2018 and three others have been named Washington, D.C. Rising Stars. The annual publication identifies lawyers who have attained a high degree of peer recognition and professional achievement.
Chair of Mintz’s Antitrust section Bruce Sokler, along with Member Rob Kidwell and attorneys, Farrah Short Shawn Skolky collaborated on an article regarding the Washington state attorney general’s office suit against the expansion efforts of Franciscan Health System.  
Eight Mintz attorneys have been named Washington, D.C. Super Lawyers for 2017 and four have been named Washington, D.C. Rising Stars. The list will be published in a special advertising supplement in The Washington Post Magazine and in a stand-alone magazine, Washington D.C. Super Lawyers Magazine.
Mintz attorneys Michael Renaud, Robert Kidwell, and Robert Moore discuss the FTC’s suit against Qualcomm in the U. S. District Court for the Northern District of California as well as the timing of the lawsuit and specifics of the FTC’s complaints against said company. 
A team of Mintz attorneys author this column discussing the Korean Fair Trade Commission’s steep fine against Qualcomm for antitrust violations and the continued antitrust concerns raised by Qualcomm’s licensing practices.
Robert G. Kidwell, Member of Mintz's Antitrust and Federal Regulatory Practice, is participating in a panel discussion at the 2016 Association of Corporate Counsel Annual Meeting. Mr. Kidwell will discuss the increasing pressure on health care providers to rein in escalating costs.
Mintz Members Bruce Sokler and Robert Kidwell, and Special Counsel Farrah Short, authored this Law360 column about the war being waged between businesses that accept payment cards and payment card fees and protective network rules.
Mintz Member Robert Kidwell is quoted in this Law360 article discussing the U.S. Supreme Court’s decision to not review the Eleventh Circuit Court of Appeals’ finding that McWane Inc. maintained monopoly power through a rebate policy.
Members Peter Saparoff and Robert Kidwell and Associates Joel Rothman and Kevin Mortimer authored this ABA’s Section of Litigation column on the trend of plaintiff investors filing a growing number of class action cases against financial institutions alleging violations of U.S. antitrust laws.
Seven Mintz attorneys have been named Washington, D.C. Super Lawyers for 2015 and five have been named Washington, D.C. Rising Stars. The list will be published in a special advertising supplement in Washington Post Magazine and in a stand-alone Washington D.C. Super Lawyers Magazine.

Events

Speaker
Nov
16
2016
Speaker
Speaker
Jun
14
2016

OHA 2016 Annual Meeting & Education Summit

Ohio Hospital Association

Hilton Columbus at Easton, Columbus, OH